Post Market Surveillance (PMS) refers to the process of monitoring the safety and effectiveness of medical products after they have been released on the market. In the context of cancer, this involves tracking and evaluating cancer drugs, medical devices, and other therapeutic interventions to ensure they continue to be safe for patients and effective in treating the disease.
